Kenneth W. Kousky, Director at Gemphire Therapeutics Inc. (GEMP), bought 223,769 shares at $10.00 ($864K) on 2016-08-10, disclosed to the SEC on 2016-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 95,439 | $0 | 0.0% |
| 2 | $6.71 | 10,439 | $70K | 8.1% |
| 3 | $6.71 | 116,891 | $784K | 90.7% |
| 4 | $10.00 | 1,000 | $10K | 1.2% |
| Total | $3.86 avg | 223,769 | $864K | 100% |